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This review presents synthesis and chemistry of nucleoside analogs, possessing an
additional fused, heterocyclic ring of the “etheno” type, such as 1,N6-ethenoadenosine,
1,N4-ethenocytidine, 1,N2-ethenoguanosine, and other related derivatives. Formation of
ethenonucleosides, in the presence of α-halocarbonyl reagents and their mechanism,
stability, and degradation, reactions of substitution and transglycosylation, as well as their
application in the nucleoside synthesis, have been described. Some of the discussed
compounds may be applied as chemotherapeutic agents in antiviral and anticancer
treatment, acting as pro-nucleosides of already known, biologically active nucleoside
analogs.
Keywords: nucleoside analogs, ethenonucleosides, wyosine, fused heterocycles, tricyclic acyclovir, antiviral
activity
INTRODUCTION
A number of base-modified nucleosides demonstrate significant biological properties, acting,
among others, as antiviral or antitumor agents. One of the possible modifications of the nucleoside
is their transformation into ethenonucleosides. Thus, nucleosides or their respective heterocyclic
bases, possessing an exocyclic amino group, as well as a neighboring endocyclic nitrogen, can
react with some bifunctional reagents (e.g., α-halocarbonyl compounds) to form products with
an additional five-membered ring of the imidazole type. The ethenonucleosides basically do not
occur in nature; the only exception here are Y-nucleosides, strongly fluorescent tricyclic derivatives
of guanosine, occurring in the anticodon loop of some phenylalanine transfer ribonucleic acids
(tRNAPhe; Blobstein et al., 1975; Kasai et al., 1976). Wyosine, i.e., 3-methyl-1,N2-(prop-1-ene-1,2-
diyl)guanosine (compound 1; Figure 1), is the simplest example of the Y-nucleosides family. The
other known ethenonucleosides, such as 1,N6-ethenoadenosine (2), 1,N4-ethenocytidine (3), 1,N2-
ethenoguanosine (4), or N2,3-ethenoguanosine (5), have been obtained via chemical modification
of parent ribonucleosides.
In the following review, we drew our attention mainly to chemistry of ethenonucleosides and
related compounds. Their biological properties, fluorescence study, antiviral action, and mutagenic
effect on the nucleic acid level have already been presented in other reviews or recent articles (e.g.,
Secrist et al., 1972; Steiner et al., 1973; Kusmierek and Singer, 1992; Golankiewicz and Ostrowski,
2006; De Clercq, 2010; Gómez-Bombarelli et al., 2011; Jahnz-Wechmann et al., 2015). Therefore,
in this review, we will focus on the chemical properties of ethenonucleosides, barely mentioning or
shortly discussing their other features.
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SYNTHESIS
Derivatives of Adenosine and Cytidine
The first ever synthesis of ethenonucleosides, a new class of
chemically modified components of nucleic acids, was reported
in the 1970’s. Thus, treatment of 9-methyladenine and 1-
methylcytidine with chloroacetaldehyde (CAA), and using them
as models for appropriate nucleosides, gave previously unknown
fluorescent bases (Kochetkov et al., 1971). In turn, a similar
reaction of adenosine and cytidine allowed to obtain the
respective nucleosidic products—1,N6-ethenoadenosine (2) and
1,N4-ethenocytidine (3; Secrist et al., 1972). The optimum pH
value for this reaction was established at 3.5 for cytosine, and
4.5 for adenosine (Kochetkov et al., 1971; Barrio et al., 1972;).
The yield of the synthesis usually varied from satisfactory to
quantitative. They also showed that another, naturally occurring
nucleoside–guanosine, fulfilled the structural requirements to
form its etheno derivative, however it practically did not react
with aq. chloroacetaldehyde (Barrio et al., 1972).
Since that time, a great number of etheno products derived
from adenosine or cytidine have been reported (e.g., Steiner
et al., 1973; Barrio et al., 1976; Kost and Ivanov, 1980; Sattsangi
et al., 1980; Leonard, 1984; Kifli et al., 2004). It has also been
shown that not only haloaldehydes and haloketones may be
applied in the synthesis of etheno derivatives of A and C. Other
reagents of a similar nature are: bromomalonaldehyde (Nair
et al., 1984), N-(tert-butoxycarbonyl)-2-bromoacetamide and 2-
chloroketenene diethyl acetal (Leonard and Cruickshank, 1985),
malonaldehyde (Seto et al., 1985), epoxy carbonyl compounds
(Nair and Offerman, 1985), 1-halooxiranes (Guengerich and
Raney, 1992), 1,2-dicarbonyl reagents (Shapiro and Hachmann,
1966) mucochloric acid (Mäki et al., 1999), or 3-chloropropyne
(Virta et al., 2003). Quite recently, Xie et al. (2014) have
reported synthesis of etheno adenosines and cytidines, via a
copper-catalyzed domino Michael oxidative cross-coupling, with
nitroolefins.
Interestingly, after decades of synthesizing ethenonucleosides
with the use of α-halocarbonyl reagents, the mechanism of their
formation still remains unclear. Regioselectivity of the reaction
is not controversial: carbonyl group of CAA reacts with the
exocyclic amino group of nucleosides, while chloromethylene
portion alkylates the endocyclic nitrogen. This has been
demonstrated in the reaction with α-haloketones, possessing
an additional alkyl substituent, i.e., α-bromopropionaldehyde
and chloroacetone (Krzyzosiak et al., 1983), or with the use of
deuterium-labeled reagents (Kost and Ivanov, 1980). However,
the sequence of events in the formation of etheno rings is
not obvious in the majority of cases. Biernat et al. (1978) and
Krzyzosiak et al. (1983) postulated an initial condensation of
carbonyl group of the α-halocarbonyl reagents and exocyclic 6-
amino group of adenosine (6; Scheme 1:mechanism A), leading
to an unstable intermediate (7). The reaction is reversible.
Intermediate 7 then undergoes intramolecular cyclization to a
stable intermediate 8, as the result of alkylation of endocyclic
N1, and this process is irreversible. Compound 8 may
now undergo dehydration to the final 1,N6-etheno product
(9). The intermediate product 8 has been isolated, and its
FIGURE 1 | Naturally occurring wyosine (1) and synthetic
ethenonucleosides.
structure confirmed by the 1H NMR data (Biernat et al.,
1978).
Another, equally convincing pathway of synthesis is presented
in Scheme 1; mechanism B. Adenosine (6) is initially alkylated
at the N1-position to furnish an intermediate product (10). This
step is irreversible, because the N-C bond in 1-alkyladenines
is very stable. However, compound 10 immediately undergoes
a ring-closure reaction, to produce compound 8 and again,
8 is converted to 9 in the dehydration step. Considering the
sequence of events in the formation of 1,N6-ethenoadenosine
(2) and its derivatives (general structure 9), we generally agree
with the previous assumption of Kost and Ivanov (1980) that
both mechanisms may take place, depending on the structure
of α-halocarbonyl reagent, applied in this transformation.
Thus, haloaldehydes and chloroacetaldehyde in particular, can
react according to the pathway A, while haloketones and 1-
halooxiranes (Guengerich and Raney, 1992) would rather react
in line with the mechanism B. In our opinion, the structure of
the starting adenosine precursor has very little or no effect on the
discussed process. The structure of substrate, however, will have a
deciding effect in the synthesis of ethenoguanosines (see Chapter
Derivatives of Guanosine).
The mechanisms presented in Scheme 1 apply to the synthesis
of 1,N4-ethenocytidine (3) as well. Other N-alkyl nucleosides
derived from A and C may also react with CAA, e.g., N6-
isopentenyladenosine (i6A), N6-methyladenosine (m6A), or N4-
methylcytosine (Barrio et al., 1972; Biernat et al., 1978; Sattsangi
et al., 1980). Because of the presence of additional N-alkyl group,
the reaction intermediates of the type 8 cannot be dehydrated
to fluorescent etheno compounds, and the reaction stops at this
stage. Other alkylated substrates, like 1-metyladenosine (m1A)
or 3-metylcytidine (m3Cyt), do not react with CAA and related
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SCHEME 1 | Two possible mechanisms of synthesis of 1,N6-ethenoadenosine and its derivatives.
SCHEME 2 | Synthesis of 1,N2-ethenoguanosine.
reagents, due to the absence of amidine system in their structures
(Barrio et al., 1972).
Derivatives of Guanosine
Much of the discussion so far concerned the synthesis of
ethenonucleosides derived from adenosine and cytidine. As
stated above, guanosine (11; Scheme 2) is almost unreactive
under conditions suitable for modification of A and C,
and therefore this nucleoside gained relatively less attention
in the beginning. However, as shown in subsequent years,
ethenoguanosine and its derivatives deserve special attention
due to their biological properties and usefulness in nucleoside
chemistry. Because of its structure, guanosine can form two
isomeric nucleosides, 1,N2-ethenoguanosine (4), called “linear”
form, and “angular” N2,3-etheno compound (5). The former
compound may be obtained from guanosine under treatment
with chloroacetaldehyde, nevertheless the yield is usually very
poor, e.g., 7.5% at pH 6.4 after 7 days (Sattsangi et al., 1977).
The yield of 4 can be improved at higher pH values, e.g., 13%
at pH 9–10, or under anhydrous conditions, by using sodium
salt of guanosine prepared in DMSO and 90% ethereal solution
of CAA (yield 24%; Boryski, 1990). However, the best yield
of the synthesis may be obtained in a two-step procedure.
As shown in Scheme 2, alkylation of guanosine (11), with
bromoacetaldehyde diethyl acetal in the presence of potassium
carbonate, leads to the 1-substituted derivative (12; O6-isomers
are usually reaction side-products), which gives an unstable
aldehyde intermediates, upon acidic hydrolysis (13). The latter
compound (corresponding to compound 10 in the synthesis of
1,N6-ethenoadenosine) undergoes a spontaneous intramolecular
cyclization and dehydration to 1,N2-ethenoguanosine (4; overall
yield 50%; Boryski, 1990; Boryski et al., 1991). In turn, another
compound of this type, a 6-hydroxymethyl derivative of 1,N2-
ethenoguanosine may be obtained in the reaction of guanosine
with glycidaldehyde (Nair and Turner, 1984). More recently, it
has been shown that a linear ethenoguanosine analog can be
synthesized in a satisfactory yield (54%), when applying CAA and
6-chloro-2-aminopurine substrates at 70◦C (Horejsi et al., 2006).
The reactions of guanosine with substituted haloketones are
much easier to perform than in the case of chloroacetaldehyde.
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SCHEME 3 | Mechanisms of synthesis of 1,N2-ethenoguanosine, N2,3-ethenoguanosine and their derivatives.
In a typical procedure (Scheme 3), guanosine is converted to its
sodium salt (14), which is readily alkylated with haloketones to
an unstable intermediate (15). Intramolecular cyclization to 16,
followed by dehydration (usually in alkaline media) results in the
formation of a linear tricyclic product (general structure 17; yield
70–90%; Kasai et al., 1976; Golankiewicz and Folkman, 1983).
Consequently, the sequence of events is obvious in this case:
the initial 1-alkylation is followed by condensation of carbonyl
group and precipitation of exocyclic amine residue. However,
O6-substiution dramatically changes the course of reaction. For
example, treatment of O6-benzylguanosine with chloroaldehyde
gives the angular N2,3-ethenoguanosine (5; Sattsangi et al., 1977;
Kusmierek et al., 1987, 1989). Our proposed mechanism for this
modification is depicted in Scheme 3. It is well-known that 3-
alkylguanosines may never be obtained by direct intermolecular
alkylation, and therefore O6-benzylguanosine (18) cannot be
alkylated with CAA at the 3-position. Instead of that, 18
undergoes an initial condensation with carbonyl group of the
aldehyde, what leads to an unstable intermediate (19). This
process is perhaps reversible, but compound 19 may undergo
an intramolecular 3-alkylation as well, forming the tricyclic
product (20). After dehydration to compound 21, the O-benzyl
substituent can be removed by applying catalytic hydrogenolysis
to obtain the final product (general structure 22; R1,R2 = H
for 5). Quite similar results were reported in the case of O6-
ethylguanosine (Kusmierek et al., 1987).
In line with the proposed mechanism, guanosine residue in
nucleic acids should be modified by CAA to the linear 1,N2-
ethenoguanosine (4). On the other hand, treatment of nucleic
acids with vinyl chloride gave, among other ethenonucleosides,
the fluorescent angular product—N2,3-ethenoguanosine (5). It
should be noted at this point that vinyl chloride, a strong
carcinogen, is metabolized in vivo to chloroacetaldehyde, which
reacts with nucleobases. (Kusmierek et al., 1987; Singer et al.,
1987). The formation of 5 can be rationalized in the following
way: guanosine, participating in the base pairing of double helix,
may exist in a tautomeric form, other than that of the free
nucleoside, i.e., O6=C–N1H→HO6–C=N1. The structure of the
second tautomer corresponds to that of the O6-alkylguanosine,
and this is why N2,3-ethenoguanosine is formed at the nucleic
acid level.
Other Ethenonucleosides
Compounds related to both forms of ethenoguanosine may
also be synthesized in the reaction of CAA with 2,6-
diaminopurine nucleosides (general structure 23; Scheme 4),
which are considerably more reactive than guanosine (Horejsi
et al., 2006). Interestingly, the reaction leads to a mixture of
linear (24) and angular (25) products. Their ratio clearly depends
on substitution in the N6-position. As reported, unsubstituted
substrate (R=H, H) gave a 1:3 mixture of 24 and 25, N6-
cyclopropyl derivative was exclusively transformed to the linear
product (24), whereas modification of N6,N6-diethyl compound
yielded only the angular isomer (25). So far, we cannot find
any rational explanation for those unexpected results. Moreover,
2,6-diaminopurine nucleosides may be considered as analogs
of both adenosine and guanosine, and if so, one could expect
rather the formation of products structurally related to 1,N6-
ethenoadenosine (2).
However, in general, the synthesis of ethenonucleosides
proceeds with high selectivity. The sugar moiety has no
substantial effect on the course and yield of this modification.
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SCHEME 4 | Formation of the etheno products in the reaction of
2,6-diaminopurine nucleosides with CAA.
Therefore, the etheno derivatives can be obtained from a variety
of protected and unprotected substrates, including e.g., ribo- and
deoxyribonucleosides, arabinofuranosides, acyclonucleosides,
their phosphates, cyclic phosphates and polynucleotide chains of
RNA and DNA.
CHEMISTRY
As far as the sugar portion is concerned, ethenonucleosides are
quite similar in their reactivity to other nucleosides. Therefore,
in the present review we shall focus our attention on reactions
involving the aglycon moiety of these etheno-bidged compounds
and their derivatives.
Alkylation
Some intensive studies on alkylation of ethenonucleosides have
been performed in the case of guanosine derivatives. The reason
for that was a close structural similarity of 1,N2-ethenoguanosine
(4) and the simplest Y-nucleoside, wyosine (1). Therefore, a direct
methylation in the 4-position of the tricylic etheno compound
would give rise to a straightforward synthesis of the fluorescent
Y-nucleosides, avoiding a laborious, multi-step procedure via
3-methylguanosine, elaborated by Itaya et al. (1980).
A common substrate for the methylation study—4-
desmethylwyosine (i.e., 6-methyl-1,N2-ethenoguanosine;
compound 26 in Scheme 5), may easily be obtained by treatment
of guanosine (6) with bromoacetone (Kasai et al., 1976).
Depending on the reaction conditions, the tricyclic system of
26 may be methylated in different positions. Thus, reaction
with diazomethane (Kasai et al., 1976) or with methyl iodide,
in the presence of potassium carbonate (Boryski and Ueda,
1985), leads to the 5-methyl product (27), a non-fluorescent
isomer of wyosine. In turn, reaction with dimethyl sulfate (DMS)
provides fluorescent 1,6-dimethyl-1,N2-ethenoguanosine (28),
a tricyclic analog of 7-methylguanosine (Golankiewicz and
Folkman, 1983). However, the same author, having carefully
SCHEME 5 | Methylation of 4-desmethylwyosine.
investigated the methylation of 26 triacetate with diazomethane,
demonstrated that triacetate of 1 is formed as a minor product
(3%) of this reaction, occurring in addition to predominant
amounts of the 5-methyl product (27). However, a major
breakthrough on the way to Y-nucleosides was the application of
the Simmons-Smith organozinc reagent, ICH2ZnI (Bazin et al.,
1987), which effectively transforms the 4-desmethylwyosine
system (26) into wyosine (1; yield ca. 70%).
Besides N-alkylation reactions, some derivatives of 4-
desmethylwyosine (26) undergo an unexpected C-7-aralkylation,
as reported by Zeidler and Golankiewicz (1998), and Ostrowski
et al. (2000, 2005). The aforementioned reaction takes place when
a bulky substituent (e.g., phenyl) is present in the 6-position of
substrates, and alkyl halides capable to form stable carbocations,
like triphenylmethyl chloride or benzyl bromide, are applied.
Ring-Opening Reactions
In general, ethenonucleosides are not very stable chemical
species. It is evident in the case of 1,N6-ethenoadenosine
(2), which upon treatment with 0.1 N sodium hydroxide at
room temperature, is almost quantitatively transformed into
a pyrimidine ring-opened compound, 3-β-d-ribofuranosyl-4-
amino-(5-imidazo-2-yl)-imidazole (29; Scheme 6; Yip and Tsou,
1973). No mechanism has been proposed for this ring-opening
reaction, but one may assume that it could be an initial
nucleophilic attack of hydroxide anion at C5, followed by
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SCHEME 6 | Ring-opening reactions of ethenonucleosides.
hydrolysis to 29. The reaction is perhaps closely related to the
well-known Dimroth rearrangement of adenine nucleosides. In
turn, the additional etheno ring of 2 and its derivatives may be
cleaved on bromination with Br2 or with N-bromosuccinimide
(NBS), providing in this way a starting adenine nucleoside
(Yamaji et al., 1977). To elucidate the reaction mechanism, the
authors postulated a complicated sequence of events, with an
initial bromination at either 7- and/or 8-position, and the final
hydrolysis of brominated intermediates.
A similar removal of the etheno ring, under oxidizing
condition, has been observed in the case of the linear 5-methyl-
1,N2-ethenoguanosine (26) and its derivatives (Boryski and
Ueda, 1985; Boryski et al., 1988a, 1996). Thus, treatment of
ethenonucleosides of the general type 17 (including 26) with NBS
or iodine in methanol, followed by alkaline hydrolysis, provides
the corresponding guanine nucleosides (type 11) in good yields.
We have not find any report on an analogous reaction of the
angular N2,3-etheno compound (5), but a similar process of
removing of the etheno bridge seems to be quite possible in that
case.
Interestingly, the stability of 1,N2-ethenoguanosine
derivatives depends on the kind of substituents in the 6-position.
As shown by Amblard et al. (2009), there is a correlation between
the stability and end electron effects of 6-aryl substituents in
tricyclic nucleosides related to the linear ethenoguanosine.
For example, a 6-(4-dialkylamino)phenyl acyclonucleoside
undergoes fast decomposition in water, at room temperature
(τ1/2 25min).
SCHEME 7 | Transglycosylation reactions of 5- and 4-methyl
ethenoguanosines.
Transglycosylation Reactions
Protected nucleosides, derived from the linear 1,N2-
ethenoguanosine, like other 6-oxopurine nucleosides (Boryski,
2008), readily undergo transglycosylation reactions, i.e., a
transfer of the sugar residue from one nitrogen atom to another.
For example, crystalline 5,6-dimethyl-1,N2-ethenoguanosine
triacetate (or 5-methyl-4-desmethylwyosine triacetate;
compound 30 in Scheme 7), when heated without solvents
at 200–230◦C for a short period of time (5–10min), isomerizes to
a fluorescent 1-(2,3,5-tri-O-acetyl)-β-d-ribofuranosyl compound
(31; Boryski, 1996). Similar results are observed in solvents, in
the presence of acidic catalysts, e.g., boiling chlorobenzene and p-
toluenesulfonic acid. The reaction is fully reversible—no matter
which isomer (30 or 31) is used as a substrate, transglycosylation
provides an almost equimolar mixture of both compounds
(the 3-glycosyl isomer is usually slightly prevailing). In turn,
wyosine triacetate (32) undergoes an irreversible isomerization
to the corresponding 1-riboside (33), under very mild conditions
(methylene chloride, 0◦C, AlCl3 as a catalyst; Glemarec et al.,
1988). This fact clearly reflects an unusual instability of the
N-glycosidic bond in Y-nucleosides (Blobstein et al., 1975; Kasai
et al., 1976).
Besides 1,N2-ethenoguanosine derivatives, the angular
N2,3-ethenoguanosine nucleosides may probably undergo
transglycosylation reactions, since they can be considered
as 6-oxopurine nucleosides, but so far this has not been
proven experimentally. Glycosyl migration reactions of other
ethenonucleosides, derived from adenosine or cytidine, have not
been reported in the literature.
APPLICATION OF ETHENO COMPOUNDS
Since their discovery in the 1970’s, ethenocleosides found
a variety of applications in the structural studies of
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SCHEME 8 | Application of 1,N6-ethenoadenosine in the synthesis of
2-azaadenosine an 2-subtituted adenosine derivatives.
macromolecules, such as nucleic acids and proteins. Due to their
fluorescence, 1,N6-ethenoadenosine (2) and 1,N4-ethenocytidine
(3), as well as their 2′-deoxy and other derivatives, were applied as
versatile probes to investigate mechanisms of enzymatic reaction
and three-dimensional structure of RNAs and DNAs. Those
rather historical applications have been described or reviewed
in many papers (e.g., Secrist et al., 1972; Barrio et al., 1972;
Steiner et al., 1973; Schulman and Pelka, 1976; Kost and Ivanov,
1980; Leonard, 1984). The formation of ethenonucleosides at
the polynucleotide level has also been intensively studied for
better understanding of the toxic influence of carcinogens on
nucleic acids, and the mechanism of mutagenesis (e.g., Singer
et al., 1987; Kusmierek and Singer, 1992; Golding et al., 1996;
Gómez-Bombarelli et al., 2011; Bonnac et al., 2013; Calabretta
and Leumann, 2013; Ogawa et al., 2013).
On the other hand, what may turn out to be more beneficial
for nucleoside chemists, the ethenonucleosides have found
applications as useful synthons in obtaining a number of
nucleoside analogs. The approach takes advantage of the fact
that etheno modified compounds undergo different reactions
than their parent nucleosides (vide ante). Thus, as shown in
Scheme 8, adenosine (6), upon treatment with CAA, can easily
SCHEME 9 | Application of 4-desmethylwyosine in the synthesis of N2-
and 3-methylguanosine.
be transformed into 1,N6-ethenoadenosine (2), which then
undergoes a pyrimidine ring-opening reaction in 0.1 N sodium
hydroxide to form 3-β-D-ribofuranosyl-4-amino-(5-imidazo-2-
yl)-imidazole (29). The latter compound, treated with sodium
nitrite in acetic acid, may be converted to a 5-aza analog of 1,N6-
ethenoadenosine (34; Yip and Tsou, 1973). Finally, removal of the
etheno ring on bromination with bromine or NBS produces 2-
azaadenosine (35), in good overall yield (Yamaji and Kato, 1975).
A similar sequence of ring-opening–ring-closure reactions has
been applied by Yamaji et al. (1976, 1977), for the synthesis of a
series of 5-substituted derivatives of 1,N6-ethenoadenosine (36),
followed by deblocking to the respective 2-substituted adenosines
(general structure 37). An analogous approach however, would
be useless in the case of 1,N4-ethenocytidine, due to the reactivity
of its C7=C8 double bond, under bromination conditions.
In turn, application of 6-methyl-1,N2-ethenoguanosine (26)
makes it possible to perform the synthesis of either N2-methyl-
or 3-methylguanosine, which cannot be obtained by direct
methylation of the parent nucleoside. As presented in Scheme 9,
guanosine (11) can be transformed into its tricylic derivatives
(26) which, depending on the methylating reagent (vide ante)
may give either 5-methyl (27) or 4-methyl (1) isomeric products.
In the final step, deblocking of 27with the use of NBS leads to N2-
methylguanosine (38; Boryski and Ueda, 1985), while removal
of the etheno ring, in the case of 4-methyl nucleoside (1), gives
3-methylguanosine (39; Boryski et al., 1988a).
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FIGURE 2 | Selected examples of antiviral acyclonucleosides derived
from 1,N2-ethenoguanine.
But perhaps the most spectacular application of etheno
compounds has been found while searching for new
antiviral nucleoside analogs. It has been demonstrated that
a potent antiviral drug, acyclovir (ACV; Zovirax; 9-(2-
hydroxyethoxymethyl)guanine; Elion et al., 1977) retains
its antiherpetic activity after chemical modification of the
1,N2-etheno type (Boryski et al., 1988b, 1991). Some selected
examples of bioactive ethenoguanines are presented in Figure 2.
The first synthesized acyclonucleoside, containing an etheno
ring, 1,N2-isopropenoacyclovir (TACV; X=A, R=CH3 Boryski
et al., 1988b), has become a leading compound when it comes
to searching for new antivirals of this type (Golankiewicz et al.,
1991, 1994, 2001; Balzarini et al., 2002; Goslinski et al., 2002,
2003; Ostrowski et al., 2005, 2006, 2009; Horejsi et al., 2006).
As suggested by Amblard et al. (2009), ethenoguanine
nucleosides probably act as prodrugs, releasing the active
acyclonucleosides (i.e., acyclovir or other biologically active
nucleoside analogs) after the hydrolysis of the etheno ring,
under physiological conditions. Indeed, the antiviral activity
is well-correlated with stability of tricyclic nucleosides. The
most unstable analogs, equipped with 6-phenyl, substituted with
electron donating groups, are the most active ones, reaching the
level of activity of the parent nucleosidic drugs. Biological activity
of the etheno acyclonucleosides has been described and discussed
in our recent review (Jahnz-Wechmann et al., 2015), and in the
previous review articles (Golankiewicz and Ostrowski, 2006; De
Clercq, 2010).
CONCLUDING REMARKS
The ethenonucleosides, along with furano- and
pyrrolopyrimidine nucleosides (Jahnz-Wechmann et al.,
2015; and references cited herein), constitute the most important
class of fused nucleosides, possessing a promising therapeutic
potential. In the present review, we focused our attention on the
relatively new literature data, concerning the ethenonucleosides,
their synthesis, chemistry and applications. Unlike the previous
papers, devoted mainly to derivatives of adenosine and
cytidine (see Section Introduction), our paper presents many
aspects of chemistry and activity of less known derivatives of
ethenoguanosine.
The state of the art in the studies of etheno compounds,
described herein, may suggest that everything in this field has
already been done, and almost everything has been elucidated.
However, at the end of this presentation, we would like to
give some examples of problems awaiting solution. Firstly,
it is still unknown whether the bioactive ethenonucleosides
would be of any use in clinical treatment of viral infections.
Can the lower toxicity and enhanced lipophilicity of etheno
prodrugs compensate their generally lower activity? Secondly,
many possible etheno prodrugs of bioactive adenosine and
cytidine have not yet been obtained, and there are almost no
reports on biological screening in this case. We do not know
what is the real stability of ethenoadenosine and ethenocytidine
derivatives under physiological conditions, which would be
critical to determine their possible therapeutic applications.
Moreover, the etheno modifications have not been reported
for a number of modified nucleosides, like aza- and deaza-
analogs, 8-substituted purine nucleosides, or derivatives of 2-
aminopurine, which could form both angular and linear etheno
isomers. Finally, the not yet studied ring opening reaction of
the angular N2,3-ethenoguanosine may find interesting synthetic
applications.
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